Detalles de la búsqueda
1.
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study.
BMJ Open
; 13(3): e069857, 2023 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944465
2.
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.
EClinicalMedicine
; 66: 102311, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38045803
3.
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation.
BMJ Open
; 12(10): e067194, 2022 10 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36270754
4.
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.
Trials
; 23(1): 697, 2022 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35986418
5.
Acute impact of self-guided mental imagery on craving in cocaine use disorder: a mixed-methods analysis of a randomized controlled trial.
Addiction
; 116(9): 2418-2430, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33405313
6.
Diagnostic Imaging in Veterinary Dental Practice.
J Am Vet Med Assoc
; 261(2): 201-203, 2022 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35905153
Resultados
1 -
6
de 6
1
Próxima >
>>